South Shore Capital Advisors

Position in JNJ — Johnson & Johnson

CIK 1852993 COHASSET, MA

Position in JNJ

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,455,261

+$94,456 QoQ

Shares Held

13,605

-1.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

3.07%

of 13F equity value

Holder Rank

#1,886

of 4,664 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

South Shore Capital Advisors holds $5,027,059 across 5 Drug Manufacturers - General names. JNJ ranks #1 (68.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	13,605	$3,455,261
2	LLY	ELI LILLY & Co	387	$464,179
3	NVS	Novartis AG	2,870	$449,786
4	MRK	Merck & Co., Inc.	3,498	$449,493
5	PFE	Pfizer Inc	8,652	$208,340

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,455,261	13,605	-1.0%	Shares	Sole	2026-07-30
2026-03-31	$3,360,805	13,749	+0.4%	Shares	Sole	2026-04-28
2025-12-31	$2,835,421	13,701	+16.4%	Shares	Sole	2026-01-21
2022-09-30	$1,923,073	11,772	+1.1%	Shares	Sole	2022-10-17
2022-06-30	$2,066,748	11,643	-4.0%	Shares	Sole	2022-10-17
2022-03-31	$2,149,977	12,131	+28.6%	Shares	Sole	2022-04-19
2021-12-31	$1,614,216	9,436	+7.0%	Shares	Sole	2022-02-11
2021-09-30	$1,423,784	8,816	-0.0%	Shares	Sole	2021-10-19
2021-06-30	$1,452,512	8,817	+4.4%	Shares	Sole	2021-07-29
2021-03-31	$1,388,593	8,449	-21.2%	Shares	Sole	2021-05-07
2020-12-31	$1,686,484	10,716	—	Shares	Sole	2021-04-13
No filing history on record for this holder in this stock.